IMUGENE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.083 AUD | -2.35% |
|
0.00% | -24.55% |
Chart calendar Imugene Limited
9f322092a7349aab72316369.Fxyudnm2jHVwkztOHkq2S76KPG6_NFFHOF6pOsOMJwg.I2n9JSn4_B0pwVB3dAvVOPyzexz9TXwsXh_EdJT4cmVabecECePeHRPSUA~201a619a6aa1f42a080d353a0907bcff
Upcoming events on Imugene Limited
Past events on Imugene Limited
| 2024-04-18 02:15 pm | Cholangiocarcinoma Foundation Conference - Abstract CF33-hNIS |
| 2024-04-17 | Business Update Call |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract Number: CT182 |
| 2024-03-27 12:00 am | ASX Small and Mid-Cap Conference |
| 2024-03-20 | NWR VirtualHealthcare Conference |
| 2024-02-28 04:27 pm | Q2 2024 Earnings Release |
| 2024-01-30 04:53 pm | December 2023 Sales and Revenue Release - Activities Report |
| 2024-01-18 02:45 pm | American Society of Clinical Oncology Gastrointestinal Cancers Symposium |
| 2024-01-09 05:30 pm | JPMorgan Healthcare Conference |
| 2023-11-29 11:00 pm | Annual General Meeting |
| 2023-11-15 06:30 pm | Business Update Call |
| 2023-11-07 | Business Update Call |
| 2023-10-31 | Society for Immunotherapy of Cancer Meeting - Abstract Number : 730 |
| 2023-10-30 06:05 pm | September 2023 Sales and Revenue Release - Activities Report |
| 2023-10-19 | European Society for Medical Oncology Congress - Poster Number : 4581 |
| 2023-10-19 | European Society for Medical Oncology Congress - Poster Number : 4720 |
| 2023-09-27 | Extraordinary Shareholders Meeting |
| 2023-08-24 08:28 pm | Q4 2023 Earnings Release |
| 2023-08-21 09:00 pm | Acquisition of Azer-cel From Precision Biosciences Inc By Imugene Limited Call |
| 2023-07-20 09:07 pm | June 2023 Sales and Revenue Release - Activities Report |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 4,13 2,40 71.97% | 4,21 3,40 23.81% | 0,00 4,20 - | 0,00 6,75 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million AUD | Released Forecast Spread | -8,12 -5,93 -37.04% | 0,00 0,00 - | -16,5 -9,70 -70.14% | 0,00 0,00 - | -49,1 -51,0 3.78% | -93,8 |
|
EBIT Million AUD | Released Forecast Spread | -8,18 -6,21 -31.81% | -10,8 -10,8 -0.05% | -18,5 -18,5 0.44% | -37,9 -34,8 -8.97% | -41,0 -43,9 6.64% | -132 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -7,78 -6,13 -26.82% | -10,5 -10,3 -2.02% | -18,5 -14,5 -27.39% | -37,9 -30,5 -24.11% | -39,2 -39,7 1.44% | -118 |
|
Net income Million AUD | Released Forecast Spread | -7,78 -6,13 -26.82% | -10,5 -10,3 -2.02% | -18,5 -14,5 -27.39% | -37,9 -30,5 -24.11% | -39,2 -39,7 1.44% | -116 |
|
EPS AUD | Released Forecast Spread | 0,00 0,00 -15.79% | 0,00 0,00 13.33% | 0,00 0,00 -37.93% | -0,01 -0,01 22.72% | -0,01 -0,01 28.49% | -0,02 |
| Announcement Date | 30/08/19 | 31/08/20 | 30/08/21 | 30/08/22 | 25/08/23 | - |
Quarterly results
| Fiscal Period | Junio | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 1,84 1,00 83.51% | 0,00 0,00 - | 0,00 0,10 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million AUD | Released Forecast Spread | -41,8 | |||||||||||
|
EBIT Million AUD | Released Forecast Spread | -5,91 -5,90 -0.12% | -6,04 -8,54 29.26% | -12,4 -10,5 -18.59% | -15,2 -15,2 -0.05% | -22,7 -17,8 -27.4% | -17,9 -24,9 28.35% | -23,2 -23,7 2.24% | -71,0 -31,8 -123.54% | -52,0 | -61,2 | -63,3 | |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -6,06 -5,88 -3.13% | -12,4 -7,61 -62.8% | -14,8 -12,8 -15.46% | -23,0 -16,2 -41.95% | -17,4 -25,8 32.55% | -21,8 -19,3 -13.06% | -68,7 -25,9 -165.65% | -52,3 | -51,8 | -52,9 | ||
|
Net income Million AUD | Released Forecast Spread | -4,79 | -6,06 -5,88 -3.13% | -12,4 -7,61 -62.8% | -14,8 -12,8 -15.46% | -23,0 -15,6 -48.12% | -17,4 -21,8 20.19% | -21,8 -20,4 -6.86% | -68,7 -25,9 -165.65% | -52,3 | -51,8 | -52,9 | |
|
EPS AUD | Released Forecast Spread | 0,00 | 0,00 0,00 0% | 0,00 0,00 -80% | 0,00 0,00 -170% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -0,01 0,00 - | -0,01 | -0,01 | -0,01 | |
| Announcement Date | 26/02/20 | 31/08/20 | 26/02/21 | 30/08/21 | 27/02/22 | 30/08/22 | 28/02/23 | 25/08/23 | 28/02/24 | - | - | - |
More events
Past sector events for Imugene Limited
| Today | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| Today | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
| 2024-04-24 04:15 pm | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-24 10:21 am | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 07:06 am | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 01:00 am | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMU Stock
- Calendar Imugene Limited
